Enhancing go-to-market strategies with real-world data
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
With the start of 2024, we are moving toward a world without third-party cookies to track consumer...
Healthcare brand marketing is at a crossroads. With patients taking a more active role in their...
As therapies become increasingly complex and personalized, it is imperative that physicians...
Background While the COVID-19 pandemic is behind us, the virus remains a concern that needs to be studied. In the first half of 2024 alone, over 23,000 people in the United States died of the disease. The virus also continues to evolve, with the FDA ...